Showing results (101-110 of 115) with videos related to
Sort By:
Pageof 12
Archives of Pathology & Laboratory Medicine|April 4, 2014
Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter studyChengquan Zhao, Zaibo Li, Ritu Nayar, et al.ACS Medicinal Chemistry Letters|September 27, 2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma"David A Sandham, Lucy Barker, Lyndon Brown, et al.AIDS (London, England)|December 15, 2017
Cancer burden attributable to cigarette smoking among HIV-infected people in North AmericaSean F Altekruse, Meredith S Shiels, Sharada P Modur, et al.Bioorganic & Medicinal Chemistry Letters|May 29, 2007
2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonistsDavid A Sandham, Clive Aldcroft, Urs Baettig, et al.ACS Medicinal Chemistry Letters|May 20, 2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of AsthmaDavid A Sandham, Lucy Barker, Lyndon Brown, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 14, 2018
Medical Intensive Care Unit Admission Among Patients With and Without HIV, Hepatitis C Virus, and Alcohol-Related Diagnoses in the United States: A National, Retrospective Cohort Study, 1997-2014Christopher T Rentsch, Janet P Tate, Tessa Steel, et al.Bioorganic & Medicinal Chemistry Letters|March 6, 2007
Potent and selective xanthine-based inhibitors of phosphodiesterase 5Nichola J Arnold, Ruth Arnold, David Beer, et al.Bioorganic & Medicinal Chemistry|September 8, 2004
Synthesis and biological properties of novel glucocorticoid androstene C-17 furoate estersDavid A Sandham, Lucy Barker, David Beattie, et al.Bioorganic & Medicinal Chemistry|September 12, 2013
Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseasesDavid A Sandham, Nicola Arnold, Heinrich Aschauer, et al.Journal of Medicinal Chemistry|February 17, 2025
Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 SynthaseGebhard Thoma, Wolfgang Miltz, Rudolf Waelchli, et al.Pageof 12